C-peptide plays different roles in T1DM, T2DM, or non-diabetic individuals, indicating that the regulation of atherosclerosis by C-peptide may be jointly influenced by blood glucose, insulin, and C-peptide concentrations. This evidence concerns the gene INS and atherosclerosis.